SCHEMBL16240652

SCHEMBL16240652

CC(C)N(C(=O)[C@@H](N)CCC(=O)O)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.54
DPP9 Q86TI2 5/20 0.54
GABRP O00591 2/20 0.54
GABRD O14764 2/20 0.54
GABRA1 P14867 2/20 0.54
GABRB1 P18505 2/20 0.54
GABRG2 P18507 2/20 0.54
GABRB3 P28472 2/20 0.54
GABRA5 P31644 2/20 0.54
GABRA3 P34903 2/20 0.54
GABRA2 P47869 2/20 0.54
GABRB2 P47870 2/20 0.54
GABRA4 P48169 2/20 0.54
GABRE P78334 2/20 0.54
GABRA6 Q16445 2/20 0.54
GABRG1 Q8N1C3 2/20 0.54
GABRG3 Q99928 2/20 0.54
GABRQ Q9UN88 2/20 0.54
CYP1A2 P05177 2/20 0.54
GRM8 O00222 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16240651 1.00 DPP4 (0.54) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240036 0.83 DPP4 (0.50) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240037 0.83 DPP4 (0.50) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240927 0.79 DPP4 (0.62) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240926 0.79 DPP4 (0.62) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16240143 0.79 BHMT (0.38) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL9366113 0.79 BHMT (0.38) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL16172007 0.79 SLC1A2 (0.39) DPP4DPP9GRIK1SLC1A3SLC1A2
SCHEMBL16240066 0.77 DPP4 (0.51) DPP4DPP9GABRPGABRDGABRA1
SCHEMBL3358170 0.77 DPP4 (0.51) DPP4DPP9GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813558-B1 GELLING AGENT AJINOMOTO KK (JP) 2018-01-17 EP disclosed
US-9522104-B2 Gelling agent AJINOMOTO CO., INC. (JP) 2016-12-20 US disclosed
CN-104105772-B Gelling agent 味之素株式会社 2016-09-21 CN disclosed
EP-2813558-A1 GELLING AGENT Ajinomoto Co., Inc. (JP) 2014-12-17 EP disclosed
US-20140341960-A1 GELLING AGENT AJINOMOTO CO., INC. (JP) 2014-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140341960-A1 GELLING AGENT CUTA, DEK, SUCLG1 DPP4 3960/4885DPP9 3955/4885GABRP 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.